LobbyingUsantibiotics lobbying by quarter
Usantibiotics's latest lobbying report covers Q2 2026, at $90K. The four quarters Q4 2025–Q3 2026 total $270K. Its first report covers Q2 2025; the issues it reports most are Pharmacy.
Usantibiotics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $270K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $90K | 1 |
| Q3 2025 | $90K | 1 |
| Q4 2025 | $90K | 1 |
| Q1 2026 | $90K | 1 |
| Q2 2026 | $90K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$450K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- White House Office4 reports
- Health & Human Services, Dept of (HHS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Rubin, Turnbull & Associates | $450K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MICHAEL BURLEY | Regional Administrator, White House Liaison, Deputy White House Liaison at U.S. Dept. of Housing & Urban Development; Deputy Assistant to the President, Deputy Director of Presidential Personnel at White House EOP | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/18for Q2 | Rubin, Turnbull & Associates | $90K |
| 04/17for Q1 | Rubin, Turnbull & Associates | $90K |
| 01/23for Q4 2025 | Rubin, Turnbull & Associates | $90K |
| 25/10/21for Q3 2025 | Rubin, Turnbull & Associates | $90K |
| 25/07/21for Q2 2025 | Rubin, Turnbull & Associates | $90K |
| 25/06/13for Q2 2025 | Rubin, Turnbull & Associates | Under $5,000 |
| 25/06/13for Q2 2025 | Rubin, Turnbull & Associates | Under $5,000 |